Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-22T08:15:45.806Z Has data issue: false hasContentIssue false
  • English
  • Français

Clinical Response and Tricyclic Plasma Levels During Treatment with Clomipramine

Published online by Cambridge University Press:  29 January 2018

L. Della Corte ,
A. D. Broadhurst ,
G. P. Sgaragli ,
S. Filippini ,
A. F. Heeley ,
H. D. James ,
C. Faravelli  and
A. Pazzagli
L. Della Corte
Affiliation:
Istituto Interfacolta di Farmacologia e Tossicologia, University of Florence, Italy
A. D. Broadhurst
Affiliation:
The West Suffolk Hospital, Hardwick Lane, Bury St Edmunds, Suffolk
G. P. Sgaragli
Affiliation:
Istituto Interfacolta di Farmacologia e Tossicologia, University of Florence, Italy
S. Filippini
Affiliation:
Clinica Psichiatrica, University of Florence, Italy
A. F. Heeley
Affiliation:
Peterborough District Hospital, Thorpe Road, Peterborough, Cambs
H. D. James
Affiliation:
Moorhaven Hospital, Bittaford, Ivybridge, S. Devon
C. Faravelli
Affiliation:
Medico interno
A. Pazzagli
Affiliation:
Clinica Psichiatrica, University of Florence, Italy
Get access Rights & Permissions [Opens in a new window]

Summary

Fifty depressed in-patients at two psychiatric units, one in Italy the other in England, were treated with clomipramine, either orally, or intravenously and orally. A comparison of clinical response with plasma levels of clomipramine and its metabolite, desmethylclomipramine, showed clear relationships especially in the case of desmethylclomipramine. In the intravenously-treated group this was linear, in the orally-treated group it was curvilinear. Plasma levels of desmethylclomipramine and administered clomipramine correlate highly.

These findings, together with the fact that significant clinical improvement was observed in only 55 per cent of the patients, suggest that titration of the administered dose to obtain more effective plasma levels of the metabolite might improve the clinical response to the drug in some patients.

Type
Papers
Information
The British Journal of Psychiatry , Volume 134 , Issue 4 , April 1979 , pp. 390 - 400
Copyright
Copyright © Royal College of Psychiatrists, 1979 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Ásberg, M., Crönholm, B., Sjöqvist, F. & Tuck, D. (1971) Relationship between plasma level and therapeutic effect of nortriptyline. British Medical Journal, 3, 331–4.Google Scholar
Benett, J. F. (1967) Is there a superior antidepressant? In: Antidepressant Drugs (eds. S. Grattini and M. N. G. Duker). Excerpta Medica ICS, 122, 375–93.Google Scholar
Biggs, J. T. & Ziegler, V. E. (1977) Protriptyline plasma levels and antidepressant response. Clinical Pharmacology and Therapeutics, 22, 269–73.Google Scholar
Braithwaite, R. A., Goulding, R., Theano, G., Bailey, J. & Coppen, A. (1972) Plasma concentration of amitriptyline and clinical response. The Lancet, i, 1297–300.Google Scholar
Broadhurst, A. D., James, H. D., Della Corte, L. & Heeley, A. F. (1977) Clomipramine plasma level and clinical response. Postgraduate Medical Journal, 53 (Suppl. 4), 139–45.Google ScholarPubMed
Burrows, G. D., Davies, B. & Scoggins, B. A. (1972) Plasma concentration of nortriptyline and clinical response in depressive illness. The Lancet, ii, 619–23.Google Scholar
Burrows, G., Scoggins, B. A., Turecek, L. R. & Davies, B. (1974) Plasma nortriptyline and clinical response. Clinical Pharmacology and Therapeutics, 16, 639–44.Google Scholar
Coppen, A., Montgomery, S., Ghose, K., Ramarao, V. A., Bailey, J., Christiansen, J., Mikkleson, P. L., van Praag, H. M., van De Poel, F., Minsker, E. J., Kozulja, V. G., Matussek, N., Kungkunz, G. & J⊘rgensen, A. (1978) Amitriptyline plasma concentration and clinical effect. The Lancet, i, 63–6.Google Scholar
Della Corte, L., Heeley, A. F., James, H. D., Broadhurst, A. D., Faravelli, C., Filippini, S. & Sgaragli, G. P. (1976) Pharmacokinetics of clomipramine in man. Evaluation of therapeutic and toxic effects. 1st USSR–ITALIAN Joint Meeting, Modena 23–25 September.Google Scholar
Dencker, H., Dencker, S. J., Green, A. & Nagy, A. (1976) Intestinal absorption, demethylation and entheropatic circulation of imipramine. Clinical Pharmacology and Therapeutics, 19, 584–6.CrossRefGoogle Scholar
Feighner, J. P., Robins, E., Guze, S. B., Woodruff, R. A., Winokur, G. & Munoz, R. (1972) Diagnostic criteria for use in psychiatric research. Archives of General Psychiatry, 26, 57–63.CrossRefGoogle ScholarPubMed
Glassman, A. H., Perel, J. M., Shostak, M., Kantor, S. J. & Fless, J. L. (1977) Clinical implications of imipramine plasma levels for depressive illness. Archives of General Psychiatry, 34, 197–204.Google Scholar
Gram, L. F., Over⊘, K. F. & Kirk, L. (1974) Influence of neuroleptics and benzodiazepines on metabolism of tricyclic antidepressants in man. American Journal of Psychiatry, 131, 863–6.Google Scholar
Gram, L. F., Reisby, N., Ibsen, I., Nagy, J. A., Dencker, S. J., Bech, P., Petersen, G. O. & Christiansen, J. (1976) Plasma levels and antidepressive effect of imipramine. Clinical Pharmacology and Therapeutics, 19, 318–24.Google Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.Google Scholar
Kragh-S⊘rensen, P., Åsberg, M. & Eggert-Hansen, C. (1973) Plasma nortriptyline levels in endogenous depression. The Lancet, i, 113–5.Google Scholar
Kupfer, D. J., Hanin, I., Spiker, D. G., Grau, T. & Coble, T. (1977) Amitriptyline plasma levels and clinical response in primary depression. Clinical Pharmacology and Therapeutics, 22, 904–11.CrossRefGoogle ScholarPubMed
Medical Research Council, Clinical Psychiatry Committee (1965) British Medical Journal, i, 881.Google Scholar
Miller, P., Luscombe, D. K., Jones, R. B., Seldrup, J., Beaumont, G. & John, V. (1977) Relationships between clinical response, plasma levels and side-effects of clomipramine (Anafranil) in general practitioner trials. Journal International Medical Research, 5, Supplement 1, 108–18.Google Scholar
Nagy, A. & Johansson, R. (1977) The demethylation of imipramine and clomipramine as apparent from their plasma kinetics. Psychopharmacology (Berlin), 54, 125–31.Google Scholar
Reisby, N., Gram, L. F., Bech, P., Nagy, A., Petersen, G. O., Ortmann, J., Ibsen, I., Dencker, S. J., Jacobsen, O., Krautwald, O., Sondergaard, I. & Christiansen, J. (1977) Imipramine: clinical effects and pharmacokinetic variability. Psychopharmacology (Berlin), 54, 263–72.CrossRefGoogle ScholarPubMed
Silverman, G. & Braithwaite, R. A. (1973) Benzodiazepines and tricyclic antidepressants plasma levels. British Medical Journal, iii, 18–20.Google Scholar
Sjöqvist, F. (1975) Assessment of antidepressants— Pharmacokinetic aspects. In Advance Medicine Topics in Therapeutics, vol. 1, 198–215. ed A. M. Breckenridge Pitman Medical.Google Scholar
Sulser, F., Vetulani, J. & Mobley, P. L. (1978) Mode of action of antidepressant drugs. Biochemical Pharmacology, 27, 257–61.Google Scholar
Whyte, S. F., McDonald, A. J., Naylor, G. J. & Moody, J. P. (1976) Plasma concentrations of protriptyline and clinical effects in depressed women. British Journal of Psychiatry, 128, 384–90.Google Scholar
Ziegler, V. E., Clayton, P. J., Taylor, J. R., Co, B. T. & Biggs, J. T. (1976) Nortriptyline plasma levels and therapeutic response. Clinical Pharmacology and Therapeutics, 20, 458–63.Google Scholar
Ziegler, V. E., Clayton, P. J. & Biggs, J. T. (1977) A comparison study of amitriptyline and nortriptyline with plasma levels. Archives General Psychiatry, 34, 607–12.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.